ZLD 2.86% 72.0¢ zelira therapeutics limited

Ann: ZLDs Diabetic Nerve Pain Drug Trial Two-Thirds Enrolled, page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 128 Posts.
    lightbulb Created with Sketch. 96
    Interesting, Sativex is also used to treat neuropathic pain and is approved in the UK, but not the US. Sativex was developed by GW Pharma. Perhaps the plan here is to use the delivery technology we developed and patented at curtin university, and then if this trial is successful, attempt to partner with a big Pharma company to conduct phase 3 trials, with the goal being the first cannabis based, FDA approved drug for neuropathic pain….fingers crossed
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
(20min delay)
Last
72.0¢
Change
0.020(2.86%)
Mkt cap ! $8.169M
Open High Low Value Volume
71.0¢ 75.0¢ 71.0¢ $2.142K 2.893K

Buyers (Bids)

No. Vol. Price($)
1 8 73.5¢
 

Sellers (Offers)

Price($) Vol. No.
80.0¢ 466 1
View Market Depth
Last trade - 13.49pm 04/10/2024 (20 minute delay) ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.